FDA approves new Alzheimer’s drug following clinical trial at Washington University,

The FDA granted approval of the drug on the condition that manufacturer, Biogen, conduct additional clinical trials., The FDA granted approval of the drug on the condition that manufacturer, Biogen, conduct additional clinical trials., Read More

Scroll to Top